The 10th World Drug Safety Congress Americas will bring together key thought leaders and experts to explore these worldwide challenges. This is your opportunity to engage and sit alongside the pioneers who are driving forward innovation in pharmacovigilance. Explore benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally. Make sure you are at the heart of the new drug safety era and participate in these critical discussions.


Heads of:

  • Pharmacovigilance

  • Drug Safety

  • Risk Management

  • QPPV

  • Patient Safety

  • Safety Surveillance

  • Post authorisation safety

  • Pharmacoepidemiology


  • Gain fresh insights into the future of the drug safety
  • Discover the building blocks for a proactive drug safety culture
  • Hear updates from key agencies including Health Canada and EMA
  • Share experiences, insights and strategies in interactive peer-to-peer roundtables, case studies and panel discussions
  • Explore developments in pharmacovigilance in Latin America
  • Rethink approaches to signal detection, management and evaluation
  • Hear directly from patients and discuss experiences and expectations
  • Evaluate harmonising of benefit-risk minimisation activities globally in drug safety
  • Examine ways to sustain transparency in pharmacovigilance operations
  • Devise practical solutions to safety data challenges using emerging technologies






Pharma Pricing & Market Access Congress